Endocrinology
From the Journals
Fournier gangrene cases surge in patients using SGLT2 inhibitors
Serious complications and death are likely if Fournier gangrene is not recognized.
Conference Coverage
Liraglutide seems safe, effective in children already on metformin
Liraglutide seems to be safe and effective for children and adolescents with type 2 diabetes who are already on metformin therapy.
From the Journals
Increase in pediatric thyroid cancers: overdiagnosis or something more?
Troubling trend may be caused in part by environmental and individual factors, though others say overdiagnosis is “a likely explanation.”
From the Journals
Knowledge gaps about long-term osteoporosis drug therapy benefits, risks remain large
A position paper makes recommendations based on findings from an NIH workshop and systematic review.
Latest News
Older women with ESRD face higher mortality, compared with male counterparts
LOS ANGELES – Further investigations regarding sex-based differences in dialysis treatment are required.
From the Journals
Few stroke patients undergo osteoporosis screening, treatment
Stroke patients are at increased risk of osteoporosis and fractures, yet few receive bone mineral density testing and treatment.
Conference Coverage
Anxiety, not depression, commonly afflicts euthyroid patients with thyroid disease
LOS ANGELES – Clinicians should focus on signs of anxiety symptoms in euthyroid patients with thyroid disease who report psychosomatic impairments...
Conference Coverage
Use of levoketoconazole improved several clinical features of Cushing’s disease
LOS ANGELES – Patients’ quality of life scores also grew.
From the Journals
Hip T scores can guide duration of osteoporosis therapy
A treat-to-target approach using total hip T scores could help guide decisions about how long women with osteoporosis should stay on bone-building...
News
Romosozumab gets FDA approval for treating osteoporosis
The pair of injections mainly works by encouraging new bone formation.
Conference Coverage
Nasal testosterone gel preserves fertility in men with hypogonadism
NEW ORLEANS – The formulation’s shorter half-life may be the reason sperm counts stayed high.